Blood tests could reveal how immunotherapy works inside cancer patients
NCT ID NCT07260370
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking at tiny particles in the blood called microRNA and circulating tumor cells in 300 cancer patients who are about to start immunotherapy. By comparing blood samples taken before and after treatment, researchers hope to see how these markers change. The goal is to better understand how immunotherapy affects the body, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Linkou Chang Gung Memorial Hospital
RECRUITINGTaoyuan City, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?